Cargando…
A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial
Dengue is an emerging infectious disease that has become the most important arboviral infection worldwide. There are four serotypes of dengue virus, DENV-1, DENV-2, DENV-3, and DENV-4, each capable of causing the full spectrum of disease. rDEN1Δ30 is a live attenuated investigational vaccine for the...
Autores principales: | Durbin, Anna P., Whitehead, Stephen S., Shaffer, Donna, Elwood, Dan, Wanionek, Kimberli, Thumar, Bhavin, Blaney, Joseph E., Murphy, Brian R., Schmidt, Alexander C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149013/ https://www.ncbi.nlm.nih.gov/pubmed/21829748 http://dx.doi.org/10.1371/journal.pntd.0001267 |
Ejemplares similares
-
Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Δ30 with those of DEN1
por: Blaney, Joseph E, et al.
Publicado: (2007) -
Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children
por: Karron, Ruth A, et al.
Publicado: (2020) -
Viral immunogenicity determines epidemiological fitness in a cohort of DENV-1 infection in Brazil
por: Pinheiro, Tauyne Menegaldo, et al.
Publicado: (2018) -
The Immunogenicity of DENV1–4 ED3s Strongly Differ despite Their Almost Identical Three-Dimensional Structures and High Sequence Similarities
por: Islam, Md. Din, et al.
Publicado: (2023) -
Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests
por: Oom, Aaron L., et al.
Publicado: (2017)